NCT02637076View on ClinicalTrials.gov

Xyrem and Brain Dopamine in Narcolepsy

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

January 23, 2020

Study Completion Date

January 23, 2020

Conditions
Narcolepsy With CataplexyHealthy Controls
Interventions
DRUG

Xyrem

single 3.0 gram dose

Trial Locations (1)

M5T 1R8

Centre for Addiction and Mental Health (CAMH), Toronto

All Listed Sponsors
lead

Centre for Addiction and Mental Health

OTHER

NCT02637076 - Xyrem and Brain Dopamine in Narcolepsy | Biotech Hunter | Biotech Hunter